Browse by all authors Browse By Author ID - Tugwell, Peter

Browse Results (16 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Torrance, G. W., Walker, V., Schultz, M., Pericak, D. and Band, P. (2000). A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis. In: D.S. Pisetsky, Arthritis & Rheumatism Abstract Supplement. 2000 Annual Scientific Meeting, ACR, Philadelphia, (S340-S340). 28 Oct - 02 Nov, 2000. 81  
Torrance, G. W., Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Band, P. (2000). A randomised trial of the effectiveness, cost effectiveness and cost utility of hylan G-F 20 for osteoarthritis of the knee. In: Abstract Book - 16th Annual Meeting of the International Society of Technology Assessment in Health Care. 16th Annual Meeting of ISTAHC, The Hague, Netherlands, (95-95). 18-21 Jun, 2000. 82  
Tugwell, Peter S., Wilson, Andrew J., Brooks, Peter M., Driedger, Michelle, Gallois, Cynthia, O'Connor, Annette M., Qualman, Ann, Santesso, Nancy, Wale, Janet and Wells, George A. (2005) Attributes and skills of an effective musculoskeletal consumer. The Journal of Rheumatology, 32 11: 2257-2261. 89   Cited 21 times in Scopus21
Raynauld, J. P., Goldsmith, C. H., Bellamy, N., Torrance, G. W., Polisson, R., Belovich, D., Pericak, D. and Tugwell, P. (2005) Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis And Cartilage, 13 2: 111-119. doi:10.1016/j.joca.2004.10.018 87   20 Cited 25 times in Scopus25 0
Bellamy, N., Bell, M. J., Goldsmith, C. H., Pericak, D., Walker, V., Raynauld, J. P., Torrance, G. W., Tugwell, P. and Polisson, R. (2005) Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis. Annals of The Rheumatic Diseases, 64 6: 881-885. doi:10.1136/ard.2004.026443 91   21 Cited 20 times in Scopus20 0
Bellamy , N., Torrance, G. W., Raynauld, J. P., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Brand, P. (2000). Health economic evaluation of hylan G-F 20 in knee osteoarthritis. In: Australian Rheumatology Associations 43rd Annual Scientific Conference - Scientific Program. Aust Rheumatology Assoc 43rd Annual Scientific Conference, Hobart, Australia, (44-44). 02-05 April, 2000. 63  
Boers, M., Brooks, P. M., Strand, V. and Tugwell, P. (1999). Introduction - OMERACT IV: Fourth International Consensus Conference on Outcome Measures in Rheumatology. In: Journal of Rheumatology : Proceedings of the OMERACT IV: Fourth International Consensus Conference on Outcome Measures in Rheumatology. OMERACT IV: Fourth International Consensus Conference on Outcome Measures in Rheumatology, CancĂșn, Mexico, (199-200). 16-20 April, 1998. 73   5
Khanna, Dinesh, Distler, Oliver, Avouac, Jerome, Behrens, Frank, Clements, Philip J., Denton, Christopher, Foeldvari, Ivan, Giannini, Edward, Huscher, Doerte, Kowal-Bielecka, Otylia, Lovell, Daniel, Matucci-Cerinic, Marco, Mayes, Maureen, Merkel, Peter A., Nash, Peter, Opitz, Christian F., Pittrow, David, Rubin, Lewis, Seibold, James R., Steen, Virginia, Strand, C. Vibeke, Tugwell, Peter S., Varga, John, Zink, Angela and Furst, Daniel E. (2009). Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and outcome measures in pulmonary arterial hypertension related to systemic sclerosis (EPOSS). In: Proceedings of OMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology. OMERACT 9: 9th International Consensus Conference on Outcome Measures in Rheumatology Clinical Trails, Kananaskis Village, AB, Canada, (2356-2361). 27-31 May, 2008. doi:10.3899/jrheum.090372 8   11 Cited 11 times in Scopus11 0
Boers, M., Strand, V., Simon, L. S., Tugwell, P. and Brooks, P. (2007) OMERACT 8 - 8th International consensus conference on outcome measures in rheumatology clinical trials. Journal of Rheumatology, 34 3: 599-599. 65   2 Cited 5 times in Scopus5
Boers, M., Simon, L., Strand, V., Brooks, P. M. and Tugwell, P. (2004). OMERACT: an ongoing evidence-based initiative to improve the quality of outcome measures in rheumatology.. In M. Boers, P. Brooks, B. Shea, L. Simon, V. Strand, P. Tugwell and G. Wells (Ed.), Evidence-Based Rheumatology 1 ed. (pp. 19-24) United Kingdom: BMJ Publishing Group. 43  
Welch, V, Singh, G, Strand, V, Fries, J, Boers, M, Ramey, D, Day, RO, Brooks, P, Tugwell, P, Clinch, J and Kristjansson, B (2001) Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity Index. Journal of Rheumatology, 28 5: 1188-1191. 43   4
Gazarian, M., Tugwell, P., Boers, M., Bombardier, C., Brooks, P. M., Day, R., Strand, V. and Wells, G. (1999) Patient based methods for assessing adverse events in clinical trials. Journal of Rheumatology, 26 1: 207-209. 48   8
Gabriel, S., Tugwell, P., OBrien, B., Yelin, E., Drummond, M., Ruff, B., Brooks, P., Bombardier, C. and Boers, M. (1999) Report of the OMERACT Task Force on Economic Evaluation. The Journal of Rheumatology, 26 1: 203-206. 37   26
Torrance, G. W., Raynauld, J. P., Bellamy, N., Goldsmith, C. H., Tugwell, P., Walker, V., Schultz, M. and Band, P. (2000). The effectiveness, cost-effectiveness and cost-utility of hylan G-F 20 in osteoarthritis of the knee: Economic results. In: D. A. Gordon, Canadian Rheumatology Association, Winter Workshop & Annual Meeting. Canadian Rheumatology Association, Winter Workshop & Annual Meeting, Lake Louise, Canada, (1814-1814). 23 - 26 February 2000. 75  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Tugwell, P., Torrance, G.W., Raynauld, J. P., Polisson, R., Pericak, D. and Walker, V. (2003). WOMAC 20, 50, 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: R. D. Altman, Poster Session. 8th World Congress of the OsteoArthritis Research Society Int, Berlin, Germany, (S82-S82). 12-15 Oct, 2003. 35  
Bellamy, N., Bell, M. J., Goldsmith, C. H., Torrance, G.W., Raynauld, J., Tugwell, P., Polisson, R., Pericak, D. and Walker, V. (2004). WOMAC 20, 50 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis. In: L. van de Putte, Osteoarthritis - Clinical aspects and treatment. Anneual European Congress of Rheumatology EULAR, Berlin, (359-359). 9-12 Jun, 2004. 45   1